Tech Company Financing Transactions

Marea Therapeutics Funding Round

Marea Therapeutics closed a $190 million financing round on 6/18/2024. Backers included Forbion Capital Partners, Perceptive Xontogeny Venture Fund and Sofinnova Partners.

Transaction Overview

Company Name
Marea Therapeutics
Announced On
6/18/2024
Transaction Type
Venture Equity
Amount
$190,000,000
Round
Undisclosed
Investors

Forbion Capital Partners (Lead Investor) (Antoine Boulanger)

Perceptive Xontogeny Venture Fund (Lead Investor) (Chris Garabedian)

Sofinnova Partners (Lead Investor) (Maha Katabi)

Third Rock Ventures (Lead Investor) (Jeffrey Tong)

venBio (Lead Investor) (Aaron Royston)

Alpha Wave Global

Omega Funds

Surveyor Capital

Proceeds Purpose
This financing will fund the company's MAR001 Phase 2 development plan and further progression of additional pipeline programs.

Company Information

Company Status
Private & Independent
Industry
Healthcare Services
Mailing Address
135 Mississippi St
San Francisco, CA 94107
USA
Phone
(415) 766-3610
Website
www.mareatx.com
Email Address
[email protected]
Overview
Cardiometabolic disease remains the largest cause of morbidity and mortality worldwide. Marea is harnessing large-scale human genetic data and adipocyte biology to develop first-in-class treatments that target critical and unaddressed drivers of cardiometabolic diseases.
Profile
Marea Therapeutics LinkedIn Company Profile
Social Media
Marea Therapeutics Company Twitter Account
Company News
Marea Therapeutics News
Facebook
Marea Therapeutics on Facebook
YouTube
Marea Therapeutics on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Josh Lehrer
  Josh Lehrer LinkedIn Profile  Josh Lehrer Twitter Account  Josh Lehrer News  Josh Lehrer on Facebook
Chief Financial Officer
Peter Thomson
  Peter Thomson LinkedIn Profile  Peter Thomson Twitter Account  Peter Thomson News  Peter Thomson on Facebook
Chief Operating Officer
Mark Joing
  Mark Joing LinkedIn Profile  Mark Joing Twitter Account  Mark Joing News  Mark Joing on Facebook
Chief Scientific Officer
Ethan Weiss
  Ethan Weiss LinkedIn Profile  Ethan Weiss Twitter Account  Ethan Weiss News  Ethan Weiss on Facebook
VP - Bus. Development
Christine Garrett
  Christine Garrett LinkedIn Profile  Christine Garrett Twitter Account  Christine Garrett News  Christine Garrett on Facebook
VP - General Counsel
Caitlin Murray
  Caitlin Murray LinkedIn Profile  Caitlin Murray Twitter Account  Caitlin Murray News  Caitlin Murray on Facebook
VP - Human Resources
Precillia Redmond
  Precillia Redmond LinkedIn Profile  Precillia Redmond Twitter Account  Precillia Redmond News  Precillia Redmond on Facebook

 

 

Browse more venture capital transactions:

Prev: 6/18/2024: bitsensing venture capital transaction
Next: 6/19/2024: Promaxo venture capital transaction

 

Share this article

 

Where The Data Comes From

Our team works diligently to record every notable VC transaction. VC investment data records reported here are sourced from company press releases and news coverage. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.